| Literature DB >> 34239721 |
Wei-Wen Su1,2, Shian-Sen Hsieh2,3, Ming-Hui Sun1,2, Henry Shen-Lih Chen1,2, Yung-Sung Lee1,2, Lan-Yan Yang4, Hsiao-Jung Tseng4.
Abstract
PURPOSE: To evaluate Humphrey visual field (VF) progression rate before and after cataract surgery in patients with open-angle glaucoma (OAG) and angle-closure glaucoma (ACG).Entities:
Year: 2021 PMID: 34239721 PMCID: PMC8241496 DOI: 10.1155/2021/7655747
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1Flowchart showing the inclusion of 77 eyes/780 tests from our Humphrey VF database that had been followed up for more than one year with at least three reliable VF tests before and after cataract surgery, respectively, and a baseline MD better than -20 dB.
Demographics and clinical characteristics among 77 eyes with open-angle and angle-closure glaucoma.
| OAG ( | ACG ( |
| |
|---|---|---|---|
| History of trabeculectomy | 7 (13.7%) | 6 (23.1%) | 0.344 |
|
| |||
| Surgical age | 58.96 ± 11.64 | 68.15 ± 13.67 | 0.002 |
|
| |||
| Preoperative logMAR | 0.57 ± 0.32 | 0.76 ± 0.41 | 0.014 |
|
| |||
| Cataract morphology | |||
| NS/CO cataract | 48 (94.1%) | 26 (100%) | 0.083 |
| PSC cataract | 20 (39.2%) | 7 (26.9%) | 0.279 |
|
| |||
| Preoperative IOP | 13.33 ± 3.37 | 14.87 ± 3.81 | 0.175 |
|
| |||
| No. of medications for glaucoma | 0.604 | ||
| Before surgery | 1 (0–3) | 1 (0–5) | 0.181 |
| After surgery | 1 (0–3) | 1 (0–2) | 0.009 |
|
| |||
| Preoperative vertical CDR | 0.77 ± 0.20 | 0.79 ± 0.16 | 0.720 |
|
| |||
| Baseline MD | −7.09 ± 5.01 | −6.52 ± 5.44 | 0.383 |
|
| |||
| Total assessment duration (years) | 9.95 (4.15–16.96) | 11.30 (4.17–16.56) | 0.166 |
| Before surgery | 4.48 (1.09–14.22) | 4.83 (1.01–12.63) | 0.927 |
| After surgery | 5.25 (1.49–10.80) | 6.07 (1.10–9.73) | 0.380 |
|
| |||
| Total no. of VF tests | 0.897 | ||
| 6–10 tests | 38 (74.51%) | 21 (80.77%) | |
| 11–15 tests | 11 (21.57%) | 5 (19.23%) | |
| 15+ tests | 2 (3.92%) | 0 (0.00%) | |
| Before surgery | 4 (3–14) | 3 (3–8) | 0.054 |
| After surgery | 4 (3–19) | 4 (3–8) | 0.798 |
Durations, VF tests, and numbers of medications are presented as median and range due to data skewness. Mann–Whitney U test (continuous) or Fisher's exact test (categorical). OAG: open-angle glaucoma; ACG: angle-closure glaucoma; logMAR: logarithm of the minimum angle of resolution; NS/CO: nuclear sclerosis/cortical opacity; PSC: posterior subcapsular; IOP: intraocular pressure; CDR: cup to disc ratio; MD: mean deviation; VF: visual field.
Figure 2Distribution of medication in OAG and ACG before and after cataract surgery.
Change in mean sensitivity and variance of VF before and after cataract surgery in patients with OAG and ACG.
| Last VF preoperatively | First VF postoperatively |
| |
|---|---|---|---|
| OAG | |||
| Mean sensitivity (dB) | 21.14 ± 6.31 | 21.70 ± 6.54 | 0.16 |
| SD of retinal sensitivity | 6.07 ± 3.28 | 6.66 ± 3.34 | 0.005 |
|
| |||
| ACG | |||
| Mean sensitivity (dB) | 18.12 ± 7.51 | 17.28 ± 7.87 | 0.154 |
| SD of retinal sensitivity | 6.36 ± 3.14 | 7.35 ± 3.46 | 0.024 |
OAG: open-angle glaucoma; ACG: angle-closure glaucoma; SD: standard deviation; VF: visual field.
Comparisons of ophthalmic measurements between two groups, before and after cataract surgery.
| OAG ( | ACG ( |
| |||||
|---|---|---|---|---|---|---|---|
| Pre-op | Post-op | Pre-op | Post-op | Group difference | Pre-op and post-op difference | Group-time interaction | |
| BCVA | |||||||
| LogMAR | 0.57 ± 0.32 | 0.18 ± 0.34 | 0.76 ± 0.41 | 0.30 ± 0.29 | 0.008 | <0.001 | 0.817 |
| Snellen | 0.33 ± 0.18 | 0.79 ± 0.26 | 0.24 ± 0.17 | 0.60 ± 0.30 | 0.002 | <0.001 | 0.046 |
| IOP (mmHg) | 13.33 ± 3.37 | 12.26 ± 3.64 | 14.87 ± 3.81 | 11.12 ± 2.92 | 0.828 | <0.001 | <0.001 |
| No. of medications | 1.31 ± 0.74 | 1.22 ± 0.61 | 1.62 ± 0.98 | 0.81 ± 0.63 | 0.723 | <0.001 | <0.001 |
| MS slope (dB/year) | −0.39 ± 0.94 | −0.47 ± 0.72 | −1.39 ± 1.31 | −0.34 ± 0.64 | 0.007 | 0.002 | <0.001 |
OAG: open-angle glaucoma; ACG: angle-closure glaucoma; BCVA: best-corrected visual acuity; logMAR: logarithm of the minimum angle of resolution; IOP: intraocular pressure; MS: mean sensitivity.
Figure 3ANOVA group-time interaction effect on (a) MD, (b) logMAR, (c) Snellen VA, (d) IOP, (e) number of medications, and (f) MS slope in OAG and ACG. MD: mean deviation; logMAR: logarithm of the minimum angle of resolution; VA: visual acuity; IOP: intraocular pressure; MS: mean sensitivity; OAG: open-angle glaucoma; ACG: angle-closure glaucoma.